Caladrius Biosciences to Host First Quarter 2023 Financial Results tmobile top up Conference Call on Thursday, May 5, 2023, at 4:30 p.m. Eastern Time

BASKING RIDGE, N.J., April 28, 2023 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (‘Caladrius’ or the ‘Company’), a clinical-stage biopharmaceutical company dedicated to the development of innovative therapies designed to treat or reverse disease, today announced that the Company will report its financial results for the three months ended March 31, 2023, on Thursday, May 5, 2023 at 4:30 p.m. (ET). To join the live conference call, please refer to the dial-in information provided below.